Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 4.342
Filtrar
2.
Medicine (Baltimore) ; 103(10): e37159, 2024 Mar 08.
Artigo em Inglês | MEDLINE | ID: mdl-38457569

RESUMO

INTRODUCTION: Pyoderma gangrenosum (PG) is a rare noninfectious neutrophilic skin disease. The diagnosis of PG is mainly based on clinical manifestations. Therefore, the clinical features of PG are important for confirming the diagnosis of this disease. Herein, the clinical data of 2 young males with PG complicated with hematological malignancies were reported, and the literature were reviewed. CASE PRESENTATION: The first case was a 22-year-old male who was admitted due to a systemic rash, headache, and fever. Physical examination showed black scabs on the skins of the extremities, trunk, scalp, and face. Biopsy of the skin lesion showed epidermal edema, spongy formation, neutrophil infiltration, acute and chronic inflammatory cell infiltration in the dermis, showing purulent inflammation with epidermal erosion. The bone marrow biopsy showed obviously active proliferation of nucleated cells, granulocytes at various stages, abnormal morphological neutrophils, and occasionally observed young red blood cells. The diagnosis of PG and chronic myelomonocytic leukemia (CMML-0) was made. The second case was a 28-year-old male who presented a swollen, painful right calf following injury and then developed ulcers on skin and soft tissues. Bone marrow biopsy showed obviously active nucleated cell proliferation, suggesting a myeloid tumor. He was also diagnosed with PG and hematological malignancies. They both received hormone and antiinfection therapy. After treatment, their body temperature, infection, and skin lesions were improved. However, both of them were readmitted and had a poor prognosis. CONCLUSIONS: PG may be associated with hematological malignancies. For patients with typical skin lesions and obvious abnormal blood routines, it is necessary to investigate the possibility of PG with hematological malignancies.


Assuntos
Neoplasias Hematológicas , Pioderma Gangrenoso , Dermatopatias , Masculino , Humanos , Adulto Jovem , Adulto , Pioderma Gangrenoso/complicações , Pioderma Gangrenoso/diagnóstico , Pele/patologia , Dermatopatias/complicações , Biópsia/efeitos adversos , Neoplasias Hematológicas/complicações
3.
Front Immunol ; 15: 1345646, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38348029

RESUMO

Dermatomyositis (DM) is a type of inflammatory myopathy with unknown causes. It is characterized by distinct skin lesions, weakness in the muscles close to the body, and the potential to affect multiple organs. Additionally, it may be associated with the presence of malignancies. The development of DM is influenced by genetic susceptibility, autoimmune response, and various external factors like cancer, drugs, and infectious agents. Psoriasis is a chronic, recurring, inflammatory, and systemic condition. Scaly erythema or plaque is the typical skin manifestation. The etiology of psoriasis involves genetic, immune, environmental and other factors. It is uncommon for a patient to have both of these diseases simultaneously, although individuals with DM may occasionally exhibit symptoms similar to those of psoriasis. Our patient was diagnosed with psoriasis in his 50s because of scalp squamous plaques, but he did not receive standard treatment. Ten years later, he developed symptoms of muscle pain and limb weakness. He was diagnosed with psoriasis complicated with dermatomyositis in our department and received corresponding treatment. Moreover, we reviewed the relevant literature to evaluate similarities and differences in clinical manifestation and treatment to other cases.


Assuntos
Dermatomiosite , Neoplasias , Psoríase , Dermatopatias , Masculino , Humanos , Dermatomiosite/complicações , Dermatomiosite/diagnóstico , Dermatomiosite/tratamento farmacológico , Psoríase/complicações , Pele/patologia , Dermatopatias/complicações , Neoplasias/complicações
4.
Exp Clin Transplant ; 22(Suppl 1): 310-314, 2024 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-38385417

RESUMO

OBJECTIVES: In kidney transplant, the use of immunosuppressive drugs, indispensable to avoid organ rejection, implies an increased risk of several infectious and neoplastic diseases. Cutaneous infections have a high incidence in kidney transplant recipients and are diagnosed in 55% to 97% of these patients. The objectives of this study were to identify the most frequent skin diseases and their clinical risk factors within a population of kidney transplant recipients. MATERIALS AND METHODS: We reviewed the medical records of 200 kidney transplant recipients at Sahloul Teaching Hospital, Tunisia, between November 2007 and January 2018. We analyzed the clinical data of patients who sought skin consultations with either dermatologists or plastic surgeons within the hospital. We collected patient sociodemographic data, type of donor, and type of immunosuppressive therapy used by recipients. We also obtained history of skin lesions and examination findings. RESULTS: Among 200 patients included in our study cohort, 131 were male and 69 were female. Age ranged from 6 to 75 years with a mean age of 30.51 ± 12 years. Patients had received kidneys from either living or deceased donors, with available data indicating 96.5% living donors and 3.5% deceased donors. The mean time interval from transplant to first skin consultation was 31 month (range, 3 months to 10 years). Prevalence of various skin conditions was 48.5%. We found that 62.9% of cases were skin infections, 59.8% were drug-induced skin conditions, and 2.9% were skin cancers. The estimated risk factors for skin lesions include use of cyclosporin and duration of immunosuppression. CONCLUSIONS: Our study demonstrated the spectrum of skin conditions that can be expected after kidney transplant. Careful dermatological screening and long-term follow-up are needed for these patients to reduce posttransplant skin complications.


Assuntos
Transplante de Rim , Dermatopatias , Neoplasias Cutâneas , Humanos , Masculino , Feminino , Adolescente , Adulto Jovem , Adulto , Criança , Pessoa de Meia-Idade , Idoso , Transplante de Rim/efeitos adversos , Prevalência , Dermatopatias/diagnóstico , Dermatopatias/epidemiologia , Dermatopatias/complicações , Neoplasias Cutâneas/epidemiologia , Fatores de Risco , Doadores Vivos , Transplantados
5.
Pediatr Dermatol ; 41(2): 234-242, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38326222

RESUMO

BACKGROUND: Despite studies of dermatologic manifestations in adults with inflammatory bowel disease (IBD), little is known about the prevalence of IBD-associated skin lesions and their correlation with IBD severity in children. We aimed to address these knowledge gaps in our single-center cohort of children with IBD. METHODS: Retrospective chart review of 528 children and adolescents (≤18 years old) with IBD and seen at Mayo Clinic (Rochester, MN) between 1999 and 2017 was conducted. The Chi-Square/Fischer's exact test (with p ≤ .05 to signify statistical significance) was applied to compare categorical outcomes between Crohn's disease (CD) and ulcerative colitis (UC) patients. RESULTS: In total, 425 IBD patients (64.9% CD, 53% males) and ≥1 dermatologic diagnosis were included. Presence of ≥1 cutaneous infection was recorded in 42.8% of participants. Acne was the most common non-infectious dermatologic condition (30.8%), followed by eczema (15.8%) and perianal skin tags (14.6%). Angular cheilitis (p = .024), keratosis pilaris (KP, p = .003), and perianal skin complications (i.e., skin tags, fistula, and abscesses; all p < .001) were more frequently diagnosed among children with CD, while fungal skin infections (p = .017) were more frequently diagnosed in UC patients. Severity of IBD correlated with higher prevalence of perianal fistula (p = .003), perianal abscess (p = .041), psoriasis (p < .001), and pyoderma gangrenosum (PG, p = .003). CONCLUSIONS: Both IBD-specific and IBD-nonspecific dermatologic conditions are very prevalent in childhood IBD, the most common being infectious. Children with CD are more likely to experience angular cheilitis, KP, and perianal skin findings than those with UC. Perianal disease, psoriasis, and PG are associated with more severe IBD.


Assuntos
Queilite , Colite Ulcerativa , Doença de Crohn , Fístula , Doenças Inflamatórias Intestinais , Psoríase , Dermatopatias , Neoplasias Cutâneas , Adulto , Masculino , Adolescente , Humanos , Criança , Feminino , Estudos Retrospectivos , Queilite/complicações , Doenças Inflamatórias Intestinais/complicações , Doenças Inflamatórias Intestinais/epidemiologia , Doença de Crohn/complicações , Doença de Crohn/epidemiologia , Doença de Crohn/diagnóstico , Colite Ulcerativa/complicações , Colite Ulcerativa/epidemiologia , Colite Ulcerativa/diagnóstico , Abscesso , Dermatopatias/etiologia , Dermatopatias/complicações , Psoríase/complicações , Psoríase/epidemiologia , Neoplasias Cutâneas/complicações , Fístula/complicações
6.
BMC Infect Dis ; 24(1): 244, 2024 Feb 22.
Artigo em Inglês | MEDLINE | ID: mdl-38388418

RESUMO

BACKGROUND: Kaposi Varicelliform Eruptions (KVE), also known as eczema herpeticum, is a rare and potentially life-threatening dermatological condition primarily attributed to herpes simplex virus (HSV) infection, with less frequent involvement of Coxsackie A16, vaccinia, Varicella Zoster, and smallpox viruses. Typically associated with pre-existing skin diseases, especially atopic dermatitis, KVE predominantly affects children but can manifest in healthy adults. Characterized by painful clusters of vesicles and sores on the skin and mucous membranes, it often masquerades as other dermatological disorders. Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used for pain relief and inflammation, though their potential role as KVE triggers remains uncertain. CASE REPORT: Here, we present a case of an 18-year-old female with KVE attributed to Varicella Zoster virus (VZV) and successfully treated with oral acyclovir within a week, underscoring the significance of early recognition and intervention. KVE can manifest with systemic symptoms like fever, fatigue, and lymphadenopathy and may involve multiple organ systems, necessitating possible antibiotic use for complications. CONCLUSION: This case underscores the importance of prompt KVE identification and consideration of antiviral therapy to enhance patient outcomes. Further research is warranted to elucidate predisposing factors for this rare condition.


Assuntos
Dermatite Atópica , Erupção Variceliforme de Kaposi , Dermatopatias , Adolescente , Feminino , Humanos , Aciclovir/uso terapêutico , Dermatite Atópica/complicações , Herpesvirus Humano 3 , Erupção Variceliforme de Kaposi/diagnóstico , Erupção Variceliforme de Kaposi/tratamento farmacológico , Erupção Variceliforme de Kaposi/complicações , Dermatopatias/complicações
7.
Front Immunol ; 15: 1275269, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38357543

RESUMO

Acne vulgaris, one of the most common skin diseases, is a chronic cutaneous inflammation of the upper pilosebaceous unit (PSU) with complex pathogenesis. Inflammation plays a central role in the pathogenesis of acne vulgaris. During the inflammatory process, the innate and adaptive immune systems are coordinately activated to induce immune responses. Understanding the infiltration and cytokine secretion of differential cells in acne lesions, especially in the early stages of inflammation, will provide an insight into the pathogenesis of acne. The purpose of this review is to synthesize the association of different cell types with inflammation in early acne vulgaris and provide a comprehensive understanding of skin inflammation and immune responses.


Assuntos
Acne Vulgar , Dermatite , Dermatopatias , Humanos , Acne Vulgar/etiologia , Pele , Inflamação/patologia , Dermatopatias/complicações , Expressão Gênica , Dermatite/complicações
8.
J Cutan Pathol ; 51(3): 193-197, 2024 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-38018231

RESUMO

During the coronavirus disease 2019 (COVID-19) pandemic, COVID-19 vaccines were administered worldwide. A number of skin reactions, including primary cutaneous T-cell lymphoproliferative disorders (LPDs) were reported following COVID-19 vaccination. We report a case of primary cutaneous marginal zone lymphoproliferative disorder (PCMZLPD) secondary to COVID-19 vaccination. A 57-year-old man presented with an erythematous nodule on his left arm at the site of vaccine inoculation following his first dose of the Moderna (mRNA-1273) vaccine a few weeks prior. The nodule continued to progress in size after the second dose. A skin biopsy specimen of the nodule showed a diffuse dermal infiltrate of small to medium-sized lymphocytes with plasma cells and histiocytes. The infiltrate was composed of CD3+ T cells with CD20+ and CD79a+ B cells. The neoplastic B cells reacted with BCL-2 and were negative for BCL-6 and CD10. Kappa light chain restriction was identified by in situ hybridization. Gene rearrangement studies revealed kappa light chain monoclonality, confirming the diagnosis of PCMZLPD. The temporal association with the Moderna vaccination and the occurrence of the lesion at the inoculation site indicate a COVID-19 vaccination-induced PCMZLPD. This is one of the rare cases of PCMZLPD following COVID-19 vaccination.


Assuntos
COVID-19 , Transtornos Linfoproliferativos , Dermatopatias , Neoplasias Cutâneas , Masculino , Humanos , Pessoa de Meia-Idade , Vacinas contra COVID-19/efeitos adversos , Neoplasias Cutâneas/patologia , COVID-19/complicações , Dermatopatias/complicações , Transtornos Linfoproliferativos/etiologia , Transtornos Linfoproliferativos/patologia , Vacinação/efeitos adversos
9.
Australas J Dermatol ; 65(2): 171-173, 2024 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-38066726

RESUMO

Calcinosis cutis is represented by the deposition of insoluble calcium salts in the skin and subcutaneous tissue. Calcinosis can lead to repeated episodes of local inflammation and repeated infections, resulting in pain and functional disability, and even death. Here, we present a case of a patient with SSc who experienced calcinosis universalis and eventually died from recurrent infections at the sacrococcygeal calcification.


Assuntos
Calcinose , Escleroderma Sistêmico , Dermatopatias , Humanos , Dermatopatias/complicações , Escleroderma Sistêmico/complicações , Calcinose/complicações , Pele , Tela Subcutânea
10.
J Eur Acad Dermatol Venereol ; 38(4): 645-656, 2024 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-38084889

RESUMO

INTRODUCTION: Several classifications of psychodermatology disorders have been proposed, with most of them based on two to four main disorder category groups. However, there is, to date, no classification that has resulted from a consensus established by psychodermatology experts. The DSM-5-TR (Diagnostic and statistical manual of mental disorders (5th ed.), Text Revision) and the ICD-11 (International classification of diseases (11th revision)) also do not provide a systematized approach of psychodermatology disorders. Taking into consideration that classifications are a key pillar for a comprehensive approach to the pathologies of each branch of medicine, the proposal of a classification in psychodermatology appeared as a central need for the recognition of psychodermatological disorders, in an attempt to improve their recognition and, in that sense, to find a common language for the development of this subspecialty that crosses dermatology and psychiatry. METHODS: Previously published classifications in psychodermatology were critically reviewed and discussed by expert opinion from an international multidisciplinary panel of 16 experts in psychodermatology and a new classification system is proposed, considering classical concepts in general dermatology and psychopathology. RESULTS: Two main categories of disorders are presented (a main group related to primary mental health disorders and another main group related to primary skin disorders), which are subsequently subdivided into subgroups considering pathophysiological and phenomenological similarities, including key aspects of dermatological examination, namely the presence of visible skin lesions (primary and secondary skin lesions) and psychopathological correlates. CONCLUSION: This new classification aims to unify previous classifications, systematize the disorders that belong to psychodermatology and highlight their tenuous boundaries, to improve their management. It has been built and approved by the Psychodermatology Task Force of the European Academy of Dermatology and Venereology (EADV), the European Society for Dermatology and Psychiatry (ESDaP) and the Association for Psychoneurocutaneous Medicine of North America (APMNA).


Assuntos
Dermatologia , Transtornos Mentais , Dermatopatias , Humanos , Dermatologia/métodos , Dermatopatias/complicações , Transtornos Mentais/psicologia , Pele , Psicopatologia
11.
Am J Obstet Gynecol MFM ; 6(1): 101226, 2024 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-37972926

RESUMO

BACKGROUND: Increased rates of adverse pregnancy outcomes have been reported in association with rheumatologic diseases such as systemic lupus erythematosus, rheumatoid arthritis, dermatomyositis. However, little is known about pregnancy outcomes in patients with autoimmune skin diseases. OBJECTIVE: This study aimed to determine the frequency of adverse pregnancy outcomes in patients with autoimmune skin diseases. We hypothesized that similar to rheumatic diseases, the rate of adverse pregnancy outcomes in patients with autoimmune skin diseases would be higher than the general population. STUDY DESIGN: This is a case control study using the TriNetX US Collaborative Network, which is a database of electronic medical records of >95 million patients seen at 57 healthcare organizations in the United States. All pregnant women between the ages of 15 and 44 years who were seen at a healthcare organization between January 1, 2016 and December 31, 2021 were included. Participants with autoimmune skin disease were matched to healthy controls and controls with systemic rheumatologic conditions (systemic lupus erythematosus or rheumatoid arthritis). For both the autoimmune skin disease and healthy control groups, those with systemic rheumatologic condition or hidradenitis suppurativa were excluded. The primary outcomes were adverse pregnancy outcomes defined as spontaneous abortion, gestational hypertension, preeclampsia or eclampsia, gestational diabetes mellitus, intrauterine growth restriction, preterm premature rupture of membranes, preterm birth, and stillbirth. Patients with autoimmune skin diseases and controls were 1:1 propensity score-matched by age, race, ethnicity, comorbidities, obesity, and substance use. For each outcome, odds ratio with a 95% confidence interval was calculated. RESULTS: A total of 2788 patients with autoimmune skin diseases were matched to 2788 healthy controls. Patients with autoimmune skin diseases were at a higher risk of spontaneous abortions than controls (odds ratio, 1.54; 95% confidence interval, 1.36-1.75; P<.001). Compared with patients with systemic lupus erythematosus, patients with autoimmune skin diseases were at lower risk of having infants with intrauterine growth restriction (odds ratio, 0.59; 95% confidence interval, 0.4-0.87; P=.01), preterm birth (odds ratio, 0.68; 95% confidence interval, 0.47-0.98; P=.04), and stillbirth (odds ratio, 0.50; 95% confidence interval, 0.25-0.97; P=.04). The differences in adverse pregnancy outcomes between patients with autoimmune skin diseases and those with rheumatoid arthritis were not statistically significant. CONCLUSION: Patients with autoimmune skin diseases are at a higher risk of spontaneous abortions than patients without autoimmune skin diseases. When analyzed by each autoimmune skin disease, patients with cutaneous lupus erythematosus or vitiligo remained at increased risk of spontaneous abortions compared with patients without autoimmune skin diseases. Patients with autoimmune skin diseases have similar risks of adverse pregnancy outcomes as patients with rheumatoid arthritis, but lower risks than patients with systemic lupus erythematosus.


Assuntos
Aborto Espontâneo , Artrite Reumatoide , Lúpus Eritematoso Sistêmico , Complicações na Gravidez , Nascimento Prematuro , Dermatopatias , Humanos , Recém-Nascido , Gravidez , Feminino , Estados Unidos/epidemiologia , Adolescente , Adulto Jovem , Adulto , Resultado da Gravidez/epidemiologia , Aborto Espontâneo/epidemiologia , Aborto Espontâneo/etiologia , Nascimento Prematuro/epidemiologia , Nascimento Prematuro/etiologia , Natimorto/epidemiologia , Estudos de Casos e Controles , Retardo do Crescimento Fetal/diagnóstico , Retardo do Crescimento Fetal/epidemiologia , Retardo do Crescimento Fetal/etiologia , Complicações na Gravidez/diagnóstico , Complicações na Gravidez/epidemiologia , Complicações na Gravidez/etiologia , Lúpus Eritematoso Sistêmico/complicações , Lúpus Eritematoso Sistêmico/diagnóstico , Lúpus Eritematoso Sistêmico/epidemiologia , Artrite Reumatoide/complicações , Artrite Reumatoide/diagnóstico , Artrite Reumatoide/epidemiologia , Dermatopatias/complicações
13.
Actas Dermosifiliogr ; 115(1): 80-83, 2024 Jan.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-37482293

RESUMO

Immune checkpoint inhibitors (ICIs) can cause immune-mediated cutaneous adverse events, including sarcoid-like reactions. The aim of this study was to retrospectively analyze clinical and histologic data from patients who developed cutaneous sarcoid-like reactions between 2019 and 2022 while under treatment with ICIs. We studied 7 patients (6 women and 1 man) with a median age of 65years. Median time to onset of symptoms was 4months. The most common presentation was papular sarcoidosis of the knees followed by subcutaneous sarcoidosis. Diagnosis was confirmed histologically in all cases, and no differences were observed relative to idiopathic sarcoidosis. Discontinuation of ICI therapy was required in just two patients. ICI-induced sarcoid-like reactions tend to be mild and generally do not require treatment discontinuation. Histologic confirmation is essential for distinguishing these reactions from tumor progression.


Assuntos
Sarcoidose , Dermatopatias , Neoplasias Cutâneas , Masculino , Humanos , Feminino , Idoso , Inibidores de Checkpoint Imunológico/efeitos adversos , Estudos Retrospectivos , Sarcoidose/induzido quimicamente , Sarcoidose/diagnóstico , Dermatopatias/induzido quimicamente , Dermatopatias/complicações , Neoplasias Cutâneas/patologia
14.
Pediatr Dermatol ; 41(1): 100-103, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-37495233

RESUMO

Morphea is an uncommon inflammatory and fibrosing disorder that has a polymorphous clinical presentation. We report two cases of morphea developing as an isotopic response after a preceding benign skin disease, accompanied by a review of the literature. This case series highlights the importance of return to care recommendations for benign skin conditions such lichen striatus and pigmented purpuric dermatoses due to the rare possibility of subsequent morphea development.


Assuntos
Eczema , Exantema , Ceratose , Esclerodermia Localizada , Dermatopatias Papuloescamosas , Dermatopatias , Humanos , Esclerodermia Localizada/complicações , Esclerodermia Localizada/diagnóstico , Prurido/complicações , Dermatopatias/complicações , Eczema/complicações , Ceratose/complicações
15.
Pediatr Dermatol ; 41(2): 354-355, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-38019098

RESUMO

Dermatological conditions associated with socio-cultural and religious practices, known as "cultural dermatoses," are commonly seen in medical practice. This article presents seven cases of children who underwent skin branding for jaundice in Southern India. Skin branding, a traditional healing method, involves applying heated objects to cause third-degree burns. Healthcare providers should be aware of these cultural practices to avoid misdiagnosis.


Assuntos
Queimaduras , Icterícia , Dermatopatias , Criança , Humanos , Pele , Icterícia/etiologia , Icterícia/complicações , Queimaduras/etiologia , Cicatrização , Dermatopatias/complicações
16.
Actas Dermosifiliogr ; 115(1): T80-T83, 2024 Jan.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-37923080

RESUMO

Immune checkpoint inhibitors (ICIs) can cause immune-mediated cutaneous adverse events, including sarcoid-like reactions. The aim of this study was to retrospectively analyze clinical and histologic data from patients who developed cutaneous sarcoid-like reactions between 2019 and 2022 while under treatment with ICIs. We studied 7 patients (6 women and 1 man) with a median age of 65years. Median time to onset of symptoms was 4months. The most common presentation was papular sarcoidosis of the knees followed by subcutaneous sarcoidosis. Diagnosis was confirmed histologically in all cases, and no differences were observed relative to idiopathic sarcoidosis. Discontinuation of ICI therapy was required in just two patients. ICI-induced sarcoid-like reactions tend to be mild and generally do not require treatment discontinuation. Histologic confirmation is essential for distinguishing these reactions from tumor progression.


Assuntos
Sarcoidose , Dermatopatias , Neoplasias Cutâneas , Masculino , Humanos , Feminino , Idoso , Inibidores de Checkpoint Imunológico/efeitos adversos , Estudos Retrospectivos , Sarcoidose/induzido quimicamente , Sarcoidose/diagnóstico , Dermatopatias/induzido quimicamente , Dermatopatias/complicações , Neoplasias Cutâneas/patologia
17.
J Cutan Pathol ; 51(1): 7-10, 2024 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-36636954

RESUMO

Rosai-Dorfman disease, also known as sinus histiocytosis with massive lymphadenopathy (SHML), is a rare subtype of reactive histiocytosis which is seldom associated with Hodgkin's and non-Hodgkin's lymphomas. To date, the coexistence in the same patient of extra nodal SHML and primary cutaneous B-cell lymphoma (PCBCL) has been reported in the literature, as metachronous diagnosis in the anatomical area of the original PCBCL or synchronous occurrence in the same lesions. However, no data have been published as for synchronous occurrence of the two pathological entities in distinct anatomical sites. Herein, we report the first ever described synchronous occurrence of PCBCL and SHML, detected in distinct lesions, affecting the same patient. The complete resolution of the patient's PCBCL after rituximab treatment and the concomitant regression of SHML suggest that this clinically benign reactive histiocytic proliferation, potentially triggered by the lymphoma microenvironment itself, may take place not only in the site of the PCBCL lesion, but also in other distant areas not directly affected by the primary cutaneous lymphoma.


Assuntos
Histiocitose Sinusal , Linfoma de Células B , Linfoma não Hodgkin , Linfoma , Dermatopatias , Humanos , Histiocitose Sinusal/patologia , Linfoma não Hodgkin/complicações , Dermatopatias/complicações , Linfoma de Células B/diagnóstico , Microambiente Tumoral
18.
Neurol Sci ; 45(4): 1803-1805, 2024 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-38127157

RESUMO

A 49-year-old man presented with a 2-year history of weakness and sensory disturbances in the bilateral lower extremities, vesicorectal dysfunction, and progressive gait disturbances. Brain MRI revealed multiple ischemic and hemorrhagic cortical/subcortical lesions with patchy enhancement involving the frontal and parietal lobes, suggesting the possibility of distal perforating arteries injury. Spine MRI revealed lesions of the cervical and thoracic spinal cord with associated enhancement. The diagnosis of malignant atrophic papulosis (Degos disease) with central nervous system involvement was prompted by the characteristic skin lesions.


Assuntos
Papulose Atrófica Maligna , Dermatopatias , Masculino , Humanos , Pessoa de Meia-Idade , Papulose Atrófica Maligna/complicações , Papulose Atrófica Maligna/diagnóstico , Dermatopatias/complicações , Dermatopatias/patologia , Medula Espinal/patologia
19.
Medicine (Baltimore) ; 102(47): e36150, 2023 Nov 24.
Artigo em Inglês | MEDLINE | ID: mdl-38013381

RESUMO

RATIONALE: Atopic dermatitis (AD) is a burdensome skin disorder, especially in children. The prevalence of children with AD is increasing year by year in China. Typical symptoms like eczema-like lesions and severe pruritus can seriously affect the sleep quality and the growth and development of pediatric patients. PATIENT CONCERNS: We observed a pair of fraternal twins, in which the younger sister had AD, while the elder one had no relevant medical history. At present, the height of the 2 individuals is significantly inconsistent, with a difference of about 10 cm. DIAGNOSES: Based on the little patient's medical history and clinical manifestations, the diagnosis of AD was made. INTERVENTIONS: This little patient was treated with oral routine antihistamines, topical glucocorticoids and Dupilumab. OUTCOMES: At present, her rash and xerosis have significant improvement. She also have relief of generalized itching and improved sleep quality. LESSONS: Previous studies have indeed shown that AD has a negative impact on children's height. This case leads us to consider the association between AD and height. It also gave us the opportunity to observe subsequent height changes after the intervention was carried out.


Assuntos
Dermatite Atópica , Exantema , Dermatopatias , Humanos , Criança , Feminino , Dermatite Atópica/diagnóstico , Prurido/etiologia , Dermatopatias/complicações , Antagonistas dos Receptores Histamínicos/uso terapêutico , Exantema/complicações , Índice de Gravidade de Doença , Resultado do Tratamento , Qualidade de Vida
20.
Medicine (Baltimore) ; 102(46): e35996, 2023 Nov 17.
Artigo em Inglês | MEDLINE | ID: mdl-37986293

RESUMO

RATIONALE: Perianal abscess is a common disease of the anus and intestine. Surgery is an important treatment option for perianal abscess. However, some patients have a long healing time, poor healing effect after surgery, or even pseudo-healing. Platelet-rich plasma (PRP) is rich in platelets that can release a large number of factors when activated and promote wound healing. Moreover, there are few reports on the use of PRP for wounds that are difficult to heal after perianal abscess surgery. PATIENT CONCERNS: The patient had reported a complaint of perianal swelling and discomfort associated with anal pain, which was considered a perianal abscess. Ceftriaxone, fumigation, and sitz bath were administered after mixed hemorrhoid and perianal abscess surgeries were performed; however, the wound remained unhealed for more than 3 months, and there was a fistula under the skin. DIAGNOSIS: Perianal color ultrasonography revealed perianal abscess. INTERVENTIONS: Autologous PRP treatment was performed 5 times for each patient. OUTCOMES: The postoperative wound healed within 15 days after 5 times PRP treatments. LESSONS: PRP is a novel treatment option for pseudo-healing.


Assuntos
Doenças do Ânus , Plasma Rico em Plaquetas , Fístula Retal , Dermatopatias , Humanos , Abscesso/cirurgia , Abscesso/complicações , Fístula Retal/etiologia , Fístula Retal/cirurgia , Doenças do Ânus/cirurgia , Pele , Dermatopatias/complicações , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA